Biotech

All Articles

Analysts dig into Avidity's DMD succeed, disclosing subtleties in records

.Avidity Biosciences pleased capitalists along with phase 1/2 data in Duchenne muscular dystrophy (D...

Actinogen's cortisol blocker fails stage 2 anxiety research

.Actinogen Medical's cortisol blocker has missed out on the primary endpoint of a phase 2 research i...

Bivictrix makes a decision going exclusive only technique to take ADC right into center

.Antibody-drug conjugates (ADCs) have been at the center of a lot of a billion-dollar biobuck licens...

TPG leadings up funds to $580M for assets throughout lifestyle scientific researches

.Possession supervisor TPG, which has supported biotechs including Sionna Therapeutics and also Sant...

Merck quits stage 3 TIGIT trial in bronchi cancer for futility

.Merck &amp Co.'s TIGIT course has experienced another drawback. Months after shuttering a stage 3 m...

After a hard year, Exscientia folds up into Recursion

.After a year determined through pipe hairstyles, the shift of its own CEO as well as layoffs, Exsci...

Cullinan, after $25M bargain, hands back bispecific to Port

.Cullinan Therapeutics was actually blown away enough with Port BioMed's bispecific invulnerable rea...

A deeper examine Intense Biotech's Brutal 15

.In this particular full week's episode of "The Top Pipe," our experts are actually diving into Brut...

Lilly encounters period 2 failing of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's celebration celebrating the commenda...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of significant management hirings, shootings...